GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (XSWX:SFZN) » Definitions » EV-to-Revenue

Siegfried Holding AG (XSWX:SFZN) EV-to-Revenue : 2.94 (As of May. 16, 2024)


View and export this data going back to 1973. Start your Free Trial

What is Siegfried Holding AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Siegfried Holding AG's enterprise value is CHF3,735 Mil. Siegfried Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1,271 Mil. Therefore, Siegfried Holding AG's EV-to-Revenue for today is 2.94.

The historical rank and industry rank for Siegfried Holding AG's EV-to-Revenue or its related term are showing as below:

XSWX:SFZN' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1   Med: 2.05   Max: 4.43
Current: 2.94

During the past 13 years, the highest EV-to-Revenue of Siegfried Holding AG was 4.43. The lowest was 1.10. And the median was 2.05.

XSWX:SFZN's EV-to-Revenue is ranked worse than
57.41% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs XSWX:SFZN: 2.94

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), Siegfried Holding AG's stock price is CHF884.00. Siegfried Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF295.55. Therefore, Siegfried Holding AG's PS Ratio for today is 2.99.


Siegfried Holding AG EV-to-Revenue Historical Data

The historical data trend for Siegfried Holding AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siegfried Holding AG EV-to-Revenue Chart

Siegfried Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 3.16 3.33 2.03 2.82

Siegfried Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 - 2.03 - 2.82

Competitive Comparison of Siegfried Holding AG's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's EV-to-Revenue falls into.



Siegfried Holding AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Siegfried Holding AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3735.157/1271.494
=2.94

Siegfried Holding AG's current Enterprise Value is CHF3,735 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1,271 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG  (XSWX:SFZN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Siegfried Holding AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=884.00/295.547
=2.99

Siegfried Holding AG's share price for today is CHF884.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was CHF295.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Siegfried Holding AG (XSWX:SFZN) Business Description

Traded in Other Exchanges
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.

Siegfried Holding AG (XSWX:SFZN) Headlines

No Headlines